Julie Papanek Grant
General Partner · Canaan Partners
General PartnerMenlo Park, CA
Julie Papanek Grant is a general partner at Canaan, where she has led biopharma investments and company formation since 2013, incubating companies including Day One Biopharmaceuticals, which she co-founded and formerly led as CEO. Her investments have included Protagonist Therapeutics, CytomX and Synthekine, and the exited Cellular Research and Labrys Biologics. Previously at Genentech in oncology business development and commercial roles, she serves on the National Cancer Advisory Board and holds an MBA from Stanford GSB, an M.Phil. from Cambridge and a B.S. from Yale.
Board seats
11 current
· PUBLIC SOURCES
Credited hits
6
· PUBLIC SOURCES
Midas years
LAST CHECKED NOV 2026
Founder rating
LAST CHECKED NOV 2026
Maintained from public sources. Not claimed. If you're Julie Papanek Grant, you can claim this profile.
Claim this profileHow claiming worksClaiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.
Track record
- Day One Biopharmaceuticalsacquired
Co-founded and incubated at Canaan by Julie Papanek Grant; public company (NASDAQ: DAWN) acquired by Servier, per Crunchbase.
Source: crunchbase.com
- Cellular Researchacquired
Acquired by Becton Dickinson; listed among Julie Grant's investments on her Canaan bio.
Source: canaan.com
- Labrys Biologicsacquired
Acquired by Teva; listed among Julie Grant's investments on her Canaan bio.
Source: canaan.com
- Protagonist Therapeuticsipo
Public company (PTGX); listed among Julie Grant's investments on her Canaan bio.
Source: canaan.com
- CytomX Therapeuticsipo
Public company (CTMX); listed among Julie Grant's investments on her Canaan bio.
Source: canaan.com
- Dermiraipo
Public company (DERM); listed among Julie Grant's investments on her Canaan bio.
Source: canaan.com
Board seats
Current board seats · 1
- Nocion TherapeuticsSource: fundraisingfox.com
Success signals
Forbes Midas List
No public record
Not listed.
Reputation
No reputation score — basis not established for this investor.
No reputation sources on file yet.
Suggest a sourceContact
Published sources only
Published contact details collected from public sources. Not a referral, and not an introduction.
Published contact
- Website
- www.canaan.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
Claimed profiles can replace or remove contact details.
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Julie Papanek Grant. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewFirm-level reviews are not attributed to Julie Papanek Grant.
Methodology
This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.
Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.
Corrections with a source: Suggest a correction.
Source record 1
- [1]
DATABASE · GlassVC catalog — Catalog record for Julie Papanek Grant — provenance: GlassVC catalog
↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals · Board seats
EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026
